FDA DEVICE FACTS
Jr Medic Blue Nitrile Examination Gloves Powder Free tested for use with Chemotherapy drugs and Fentanyl Citrate
Jr Engineering & Medical Technologies (M) Sdn. Bhd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Jr Medic Blue Nitrile Examination Gloves Powder Free tested for use with Chemotherapy drugs and Fentanyl Citrate is a disposable device intended for medical purpose that is worn on the examiner’s hand to prevent contamination between patient and examiner. Additionally, the gloves were tested for use with chemotherapy drugs and Fentanyl Citrate in accordance with ASTM D6978-05 (2019) Standard Practice for Assessment of Medical Glove to Permeation by Chemotherapy Drugs. The tested chemotherapy drugs and their breakthrough detection times are as follows: Tested Chemotherapy Drug Name & Concentration Minimum Breakthrough Detection Time Bendamustine (5 mg/ml) >240 Minutes Bleomycin (15 mg/ml) >240 Minutes Busulfan (6 mg/ml) >240 Minutes Carfilzomib (2 mg/ml) >240 Minutes Cetuximab (2 mg/ml) >240 Minutes Cladribine (1 mg/ml) >240 Minutes Cytarabine (100 mg/ml) >240 Minutes Daunorubicin HCl (5 mg/ml) >240 Minutes Decitabine (5 mg/ml) >240 Minutes Docetaxel (10 mg/ml) >240 Minutes Epirubicin HCl (2 mg/ml) >240 Minutes Fludarabine (25 mg/ml) >240 Minutes Fulvestrant (50 mg/ml) >240 Minutes Gemcitabine (38 mg/ml) >240 Minutes Idarubicin HCl (1 mg/ml) >240 Minutes Irinotecan (20 mg/ml) >240 Minutes Mechlorethamine (1 mg/ml) >240 Minutes Melphalan (5 mg/ml) >240 Minutes Oxaliplatin (5 mg/ml) >240 Minutes Paraplatin (10 mg/ml) >240 Minutes Pemetrexed (25 mg/ml) >240 Minutes Raltitrexed (0.5 mg/ml) >240 Minutes Rituximab (10 mg/ml) >240 Minutes Topotecan (1 mg/ml) >240 Minutes Triclosan (2 mg/ml) >240 Minutes Trisenox (1 mg/ml) >240 Minutes Velcade (Bortezomib) (1 mg/ml) >240 Minutes Vidaza (Azacytidine) (25 mg/ml) >240 Minutes Vinblastine (1 mg/ml) >240 Minutes Vinorelbine (10 mg/ml) >240 Minutes Carmustine (BCNU) (3.3 mg/ml) 35.0 Minutes Carboplatin (10 mg/ml) >240 Minutes Cisplatin (1 mg/ml) >240 Minutes Cyclophosphamide (Cytoxan) (20 mg/ml) >240 Minutes Dacarbazine (10.0 mg/ml) >240 Minutes Doxorubicin HCl (2 mg/ml) >240 Minutes Etoposide (20 mg/ml) >240 Minutes Fluorouracil (50 mg/ml) >240 Minutes Ifosfamide (50 mg/ml) >240 Minutes Methotrexate (25 mg/ml) >240 Minutes Mitomycin C (0.5 mg/ml) >240 Minutes Mitoxantrone (2 mg/ml) >240 Minutes Paclitaxel (6 mg/ml) >240 Minutes Thiotepa (10 mg/ml) 64.9 Minutes Vincristine Sulfate (1 mg/ml) >240 Minutes The following hazardous drugs (opioid) and concentration had no breakthrough detected up to 240 minutes: Fentanyl Citrate Injection (100 mcg/2ml) Please note that the following drugs have low permeation times: Carmustine (BCNU) (3.3 mg/ml) 35.0 Minutes Thiotepa (10 mg/ml) 64.9 Minutes Warning: Do not use with Carmustine or Thiotepa.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。